ARLINGTON, Va.--(BUSINESS WIRE)--The Office of the National Coordinator for Health IT (ONC) has named Surescripts as an ONC Program Partner for Electronic Prescribing (45 C.F.R. § 170.315(b)(3)) and ...

Transactional data from the Surescripts electronic prescribing network may be used to track electronic health record adoption efficiently and with regional granularity. This study compared national ...

The settlement comes after a federal court determined that Surescripts holds a 95% 'supershare' for e-prescribing services. The Federal Trade Commission announced Thursday that it has reached a ...

Electronic prescribing company Surescripts has terminated its contract with ReMy Health, claiming new allegations about the startup's fraudulent behavior. The move has serious repercussions for Amazon ...

ARLINGTON, Va.--(BUSINESS WIRE)--In 2021, Surescripts delivered its enhanced Medication History services to providers nationwide, with a 21% increase in the use of Medication History during patient ...

Electronic prescription company Surescripts has released a new service that gives pharmacists access to information on out-of-pocket prescription costs and drug alternatives. The service, called ...

Electronic prescribing company Surescripts has fired back at the Federal Trade Commission (FTC) in its antitrust case and filed a motion to dismiss the FTC's charges in federal court Friday. The FTC ...

Through a new partnership, all users of eClinicalWorks software will have access to Surescripts’ electronic prior authorization service. Surescripts’ CompletEPA solution will be integrated into the ...

Surescripts, and Clear, an identity platform specializing in security, released a joint case study, Surescripts and Clear: Enhancing Provider Access & Security, highlighting how their collaboration is ...

As COVID-19 reshaped American health care, interoperability showed real progress with care providers using shared health intelligence more than ever to make care better, safer and more cost-effective, ...

Surescripts has moved to dismiss the Federal Trade Commission's charge from earlier this year that it holds an illegal monopoly on the e-prescribing market. This past April, the FTC alleged that ...